Dark Forest Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-14,225
| Closed | -$1.01M | – | 1192 |
|
|
2025
Q1 | $1.01M | Buy |
+14,225
| New | +$1.01M | 0.05% | 685 |
|
|
2024
Q4 | – | Sell |
-5,663
| Closed | -$398K | – | 960 |
|
|
2024
Q3 | $398K | Buy |
+5,663
| New | +$398K | 0.05% | 484 |
|
|
2023
Q4 | – | Sell |
-17,388
| Closed | -$1.54M | – | 533 |
|
|
2023
Q3 | $1.54M | Buy |
17,388
+9,108
| +110% | +$806K | 0.12% | 237 |
|
|
2023
Q2 | $718K | Buy |
8,280
+7,901
| +2,085% | +$685K | 0.07% | 454 |
|
|
2023
Q1 | $36.9K | Buy |
+379
| New | +$36.9K | 0.01% | 890 |
|
|
2022
Q4 | – | Sell |
-708
| Closed | -$60K | – | 1165 |
|
|
2022
Q3 | $60K | Buy |
+708
| New | +$60K | 0.01% | 502 |
|
|
2021
Q4 | – | Sell |
-90
| Closed | -$7K | – | 1445 |
|
|
2021
Q3 | $7K | Buy |
+90
| New | +$7K | ﹤0.01% | 1037 |
|